Difference in sensitivity between SARS-CoV-2-specific T cell assays in patients with underlying conditions. Reply.

Tan, Anthony T; Le Bert, Nina; Bertoletti, Antonio

Tan, Anthony T; Le Bert, Nina; Bertoletti, Antonio.

Tan AT; Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore.
Le Bert N; Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore.
Bertoletti A; Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore.

J Clin Invest ; 131(24)2021 12 15.

Article in English | MEDLINE | ID: covidwho-1575716

Subject(s)

COVID-19; SARS-CoV-2; Antibodies, Viral; Humans; Immunity, Humoral; T-Lymphocytes

Keywords

Adaptive immunity; COVID-19

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Limits: Humans Language: English Year: 2021 Document Type: Article Affiliation country: JCI155701

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google